GeoMx Digital Spatial Profiler (DSP) Now Enables Multi-Analyte Spatial Analysis Using Both NGS and nCounter Read-outs SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading ...

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the development of a spatial molecular imaging platform, ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed publication ...

SEATTLE and CAMBRIDGE, UK, April 01, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products ...

Oversubscribed Early Access Launch Closes with Five DSP Beta Instruments Designated for Leading Academic and Industrial Research Facilities Now Taking Orders for 2019 Delivery of Commercial GeoMx ...

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, and Visiopharm, a world leader in AI-driven digital pathology software, announced a ...

Digital spatial profiling (DSP) on the NanoString GeoMx platform enables high plex molecular profiling of clinical tissue samples. This new profiling strategy enables deep insights into the ...

Shares of laboratory equipment manufacturer NanoString Technologies (NSTG) have soared 121% since the beginning of the year. The main catalyst hasn't been improving financial performance, but rather ...

Biotechnology in the 21st century is beginning to bear the fruit promised at the beginning of the Human Genome Project over two decades ago. The massive amounts of information derived from that and ...

NanoString Technologies, joined by three of its subsidiaries, have filed for protection from creditors under Chapter 11 of the U.S. Bankruptcy Code, blaming the $31 million jury award assessed against ...

Investors will be focused on a potentially trajectory-altering product launch, but it will be several quarters (at least) before we can start drawing conclusions about its impact. The product in ...